Trials / Unknown
UnknownNCT05577481
Neuronavigation Guided iTBS With Personalized Target for Depression
Research on the Efficacy and Brain Network Mechanism of Personalized Targeting Intermittent Theta Burst Stimulation (iTBS) Based on Functional Magnetic Resonance Imaging for the Treatment of Major Depressive Disorder
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The study will compare the efficacy of intermittent Theta Burst Stimulation (iTBS) with DLPFC-pgACC personalized target for major depressive disorder (MDD) and explore possible brain network mechanisms. The stimulated targets will be located by magnetic resonance imaging (MRI) based on functional MRI based on functional connectivity respectively. This study aims to identify that functional connectivity targeted iTBS protocols on DLPFC-pgACC personalized target have a better antidepressant efficacy compared the sham group and certify that pgACC is an effective potential effector target.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | sham iTBS combined with antidepressants | Two sessions of sham prolonged iTBS (1800 pulses) per day over 10 days combined with antidepressants. |
| COMBINATION_PRODUCT | iTBS combined with antidepressants | Two sessions of prolonged iTBS (1800 pulses) per day over 10 days combined with antidepressants. |
Timeline
- Start date
- 2023-07-10
- Primary completion
- 2024-08-01
- Completion
- 2024-08-01
- First posted
- 2022-10-13
- Last updated
- 2024-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05577481. Inclusion in this directory is not an endorsement.